BIOMAT Database Logo BIOMAT Database Logo

Adipokine and Cytokine Profiles of Epicardial and Subcutaneous Adipose Tissue in Patients with Coronary Heart Disease. 2017

O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
Research Institute of Complex Problems of Cardiovascular Diseases, Kemerovo, Russia. o_gruzdeva@mail.ru.

The content of adipokines, pro- and anti-inflammatory cytokines were studied in adipocytes isolated from epicardial and subcutaneous adipose tissue of 24 coronary heart disease patients. The content of leptin and soluble leptin receptor in adipocytes of epicardial adipose tissue was higher by 28.6 and 56.9% and the level of adiponectin was lower by 33% than in adipocytes of the subcutaneous fat. In culture of epicardial adipocytes, the levels of proinflammatory cytokines TNF-α and IL-1 were higher. Subcutaneous adipose tissue adipocytes were characterized by higher levels of anti-inflammatory cytokines IL-10 and FGF-β. In epicardial adipocytes of coronary heart disease patients, the concentrations of leptin, TNF-α, and IL-1 were higher, while the levels of defense regulatory molecules (adiponectin, IL-10, and FGF-β) were lower than in subcutaneous adipocytes.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005346 Fibroblast Growth Factors A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family. DNA Synthesis Factor,Fibroblast Growth Factor,Fibroblast Growth Regulatory Factor,Growth Factor, Fibroblast,Growth Factors, Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
Lipid Profiling in Epicardial and Subcutaneous Adipose Tissue of Patients with Coronary Artery Disease.
October 2020, Journal of proteome research,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease.
January 2023, Frontiers in cardiovascular medicine,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery.
April 2022, Atherosclerosis plus,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
Association between epicardial adipose tissue and adverse outcomes in coronary heart disease patients with percutaneous coronary intervention.
May 2019, Bioscience reports,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
lncRNA expression profiles and associated ceRNA network analyses in epicardial adipose tissue of patients with coronary artery disease.
January 2021, Scientific reports,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
[Correlation between epicardial adipose tissue and coronary flow reserve in coronary heart disease patients with no chest pain].
December 2014, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
Epicardial adipose tissue in patients with heart failure.
July 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
[Relationship between epicardial adipose tissue and clinical prognosis of patients with coronary heart disease after percutaneous coronary intervention].
January 2018, Zhonghua yi xue za zhi,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
Epicardial and subcutaneous adipose tissue Fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft.
January 2013, BioImpacts : BI,
O V Gruzdeva, and O E Akbasheva, and Yu A Dyleva, and L V Antonova, and V G Matveeva, and E G Uchasova, and E V Fanaskova, and V N Karetnikova, and S V Ivanov, and O L Barbarash
Epicardial Adipose Tissue in Patients with Coronary Artery Disease: A Meta-Analysis.
August 2022, Journal of cardiovascular development and disease,
Copied contents to your clipboard!